ERBB2 and neoplasm: The tumor specimens were pathologically classified as triple‐positive (ER, PR, and HER2 positive; n = 9), triple‐negative (ER, PR, and HER2 negative; n = 5), Her2 overexpressing (n = 1), and hormone‐positive (ER/PR positive; n = 21) subtypes.